246 related articles for article (PubMed ID: 17662696)
21. Regulation of the MDR1 promoter by E2F1 and EAPP.
Andorfer P; Rotheneder H
FEBS Lett; 2013 May; 587(10):1504-9. PubMed ID: 23542036
[TBL] [Abstract][Full Text] [Related]
22. The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model.
El-Khoury V; Breuzard G; Fourré N; Dufer J
Br J Cancer; 2007 Aug; 97(4):562-73. PubMed ID: 17667922
[TBL] [Abstract][Full Text] [Related]
23. [Establishment of a drug resistant leukemia cell line caused by mdr1 gene].
Gu L; Liu T; Gong YP
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jul; 36(4):475-6, 509. PubMed ID: 16078564
[TBL] [Abstract][Full Text] [Related]
24. Selective inhibition of P-glycoprotein expression in multidrug-resistant tumor cells by a designed transcriptional regulator.
Xu D; Ye D; Fisher M; Juliano RL
J Pharmacol Exp Ther; 2002 Sep; 302(3):963-71. PubMed ID: 12183653
[TBL] [Abstract][Full Text] [Related]
25. Overcoming the classical multidrug resistance phenotype by adenoviral delivery of anti-MDR1 short hairpin RNAs and ribozymes.
Kaszubiak A; Holm PS; Lage H
Int J Oncol; 2007 Aug; 31(2):419-30. PubMed ID: 17611700
[TBL] [Abstract][Full Text] [Related]
26. A structure-function relationship among reserpine and yohimbine analogues in their ability to increase expression of mdr1 and P-glycoprotein in a human colon carcinoma cell line.
Bhat UG; Winter MA; Pearce HL; Beck WT
Mol Pharmacol; 1995 Oct; 48(4):682-9. PubMed ID: 7476894
[TBL] [Abstract][Full Text] [Related]
27. Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells.
Muller C; Goubin F; Ferrandis E; Cornil-Scharwtz I; Bailly JD; Bordier C; Bénard J; Sikic BI; Laurent G
Mol Pharmacol; 1995 Jan; 47(1):51-6. PubMed ID: 7838133
[TBL] [Abstract][Full Text] [Related]
28. CtBP1 transactivates RAD51 and confers cisplatin resistance to breast cancer cells.
Deng Y; Guo W; Xu N; Li F; Li J
Mol Carcinog; 2020 May; 59(5):512-519. PubMed ID: 32124501
[TBL] [Abstract][Full Text] [Related]
29. Association of mdr1 gene expression with other prognostic factors and clinical outcome in human breast cancer.
Punyammalee B; Manoromana S; Purisa W; Chariyalertsak S; Rerkamnuaychok B
J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S162-73. PubMed ID: 9347665
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional regulation of MDR-1 by HOXC6 in multidrug-resistant cells.
Kim KJ; Moon SM; Kim SA; Kang KW; Yoon JH; Ahn SG
Oncogene; 2013 Jul; 32(28):3339-49. PubMed ID: 22907429
[TBL] [Abstract][Full Text] [Related]
31. Trps1 is associated with the multidrug resistance of osteosarcoma by regulating MDR1 gene expression.
Jia M; Hu J; Li W; Su P; Zhang H; Zhang X; Zhou G
FEBS Lett; 2014 Mar; 588(5):801-10. PubMed ID: 24491996
[TBL] [Abstract][Full Text] [Related]
32. Genetic and epigenetic modeling of the origins of multidrug-resistant cells in a human sarcoma cell line.
Chen KG; Wang YC; Schaner ME; Francisco B; Durán GE; Juric D; Huff LM; Padilla-Nash H; Ried T; Fojo T; Sikic BI
Cancer Res; 2005 Oct; 65(20):9388-97. PubMed ID: 16230402
[TBL] [Abstract][Full Text] [Related]
33. MDR1 gene overexpression and altered degree of methylation at the promoter region in bladder cancer during chemotherapeutic treatment.
Tada Y; Wada M; Kuroiwa K; Kinugawa N; Harada T; Nagayama J; Nakagawa M; Naito S; Kuwano M
Clin Cancer Res; 2000 Dec; 6(12):4618-27. PubMed ID: 11156211
[TBL] [Abstract][Full Text] [Related]
34. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
35. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
36. Novel approaches to reversing anti-cancer drug resistance using gene-specific therapeutics.
Kobayashi H; Takemura Y; Miyachi H
Hum Cell; 2001 Sep; 14(3):172-84. PubMed ID: 11774737
[TBL] [Abstract][Full Text] [Related]
37. Preferential expression of a mutant allele of the amplified MDR1 (ABCB1) gene in drug-resistant variants of a human sarcoma.
Chen KG; Lacayo NJ; Durán GE; Wang Y; Bangs CD; Rea S; Kovacs M; Cherry AM; Brown JM; Sikic BI
Genes Chromosomes Cancer; 2002 Aug; 34(4):372-83. PubMed ID: 12112526
[TBL] [Abstract][Full Text] [Related]
38. The mechanism of trans-activation of the MDR1 gene by human T-cell leukemia virus.
Lau A; Gant TW; Cann AJ
Biochem Biophys Res Commun; 1998 Aug; 249(2):397-404. PubMed ID: 9712708
[TBL] [Abstract][Full Text] [Related]
39. Reverse multidrug resistance in laryngeal cancer cells by knockdown MDR1 gene expression.
Zhigang H; Qi Z; Jugao F; Xiaohong C; Wei Z; Hong W; Hu H; Na M; Zheng Y; Demin H
J Otolaryngol Head Neck Surg; 2009 Aug; 38(4):440-8. PubMed ID: 19755084
[TBL] [Abstract][Full Text] [Related]
40. Complete in vivo reversal of the multidrug resistance phenotype by jet-injection of anti-MDR1 short hairpin RNA-encoding plasmid DNA.
Stein U; Walther W; Stege A; Kaszubiak A; Fichtner I; Lage H
Mol Ther; 2008 Jan; 16(1):178-86. PubMed ID: 17878902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]